- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Homozygous familial hypercholesterolaemia is a rare life-threatening disease characterized by the difficulty of your body to remove LDL “bad” cholesterol from your blood. The condition raises the chance of a heart attack at an early age, but some treatments can lower your risk.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PCSK9 |
Monoclonal Antibody |
Repatha® |
140 mg/mL |
– |
3,5 mg |
-80 °C |
06/2025 |
135,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin